{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:20:48Z","timestamp":1790194848114,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejphar.2021.174584","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:47:02Z","timestamp":1634820422000},"page":"174584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters"],"prefix":"10.1016","volume":"912","author":[{"given":"Peter","family":"Kilfoil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun Lily","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asser","family":"Bassyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-9831","authenticated-orcid":false,"given":"Tiffany","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Leishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"MacEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-2417","authenticated-orcid":false,"given":"Parveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-236X","authenticated-orcid":false,"given":"Stephen","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174584_bib1","series-title":"Selected Papers of Hirotugu Akaike","first-page":"199","article-title":"Information theory and an extension of the maximum likelihood principle","author":"Akaike","year":"1998"},{"key":"10.1016\/j.ejphar.2021.174584_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2021.174584_bib3","author":"Anon"},{"key":"10.1016\/j.ejphar.2021.174584_bib4","first-page":"353","article-title":"An analysis of the time\u2010relations of the electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2021.174584_bib5","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2021.174584_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2021.174584_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro Proarrhythmia assay (CiPA) initiative - update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2021.174584_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106898","article-title":"A Bayesian approach to toxicological testing","volume":"105","author":"Felli","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2021.174584_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A new perspective in the field of cardiac safety testing through the comprehensive in vitro Proarrhythmia assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejphar.2021.174584_bib10","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1161\/01.RES.0000079028.31393.15","article-title":"Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG","volume":"92","author":"Ficker","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.174584_bib11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/bioinformatics\/btw680","article-title":"tcpl: the ToxCast pipeline for high-throughput screening data","volume":"33","author":"Filer","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2021.174584_bib12","first-page":"61133","article-title":"International conference on harmonisation; guidance on S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals; availability. Notice","volume":"70","year":"2005","journal-title":"Fed. Regist."},{"key":"10.1016\/j.ejphar.2021.174584_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","article-title":"Die systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken","volume":"53","author":"Fridericia","year":"1920","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.ejphar.2021.174584_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.ejphar.2021.174584_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCRESAHA.118.311209","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes as models for cardiac channelopathies: a primer for non-electrophysiologists","volume":"123","author":"Garg","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.174584_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.stem.2017.06.005","article-title":"The evolving roles of human iPSC-derived cardiomyocytes in drug safety and discovery","volume":"21","author":"Gintant","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2021.174584_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104756","article-title":"Repolarization studies using human stem cell-derived cardiomyocytes: validation studies and best practice recommendations","volume":"117","author":"Gintant","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174584_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/17460441.2020.1736549","article-title":"The roles of human induced pluripotent stem cell-derived cardiomyocytes in drug discovery: managing in vitro safety study expectations","volume":"15","author":"Gintant","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2021.174584_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.32614\/RJ-2016-042","article-title":"An interactive web-tool for ROC curve analysis using R language environment","volume":"8","author":"Goksuluk","year":"2016","journal-title":"R J."},{"key":"10.1016\/j.ejphar.2021.174584_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vascn.2017.11.001","article-title":"Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes","volume":"90","author":"Goodrow","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2021.174584_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na(+) channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174584_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2021.174584_bib23","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1021\/jacs.5b06644","article-title":"A photostable silicon rhodamine platform for optical voltage sensing","volume":"137","author":"Huang","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2021.174584_bib24","first-page":"25","article-title":"Evaluation of batch variations in induced pluripotent stem cell-derived human cardiomyocytes from 2 major suppliers","volume":"156","author":"Huo","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2021.174584_bib25","doi-asserted-by":"crossref","first-page":"H913","DOI":"10.1152\/ajpheart.00819.2012","article-title":"Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype","volume":"305","author":"Ivashchenko","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2021.174584_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174584_bib27","author":"Johnson"},{"key":"10.1016\/j.ejphar.2021.174584_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jphs.2018.10.010","article-title":"Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update","volume":"138","author":"Kanda","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174584_bib29","series-title":"Caret: Classification and Regression Training","author":"Kuhn","year":"2020"},{"key":"10.1016\/j.ejphar.2021.174584_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cpt.367","article-title":"Improved prediction of drug-induced Torsades de Pointes through simulations of Dynamics and machine learning algorithms","volume":"100","author":"Lancaster","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174584_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4196\/kjpp.2016.20.1.119","article-title":"Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization","volume":"20","author":"Lee","year":"2016","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.ejphar.2021.174584_bib32","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R. News"},{"key":"10.1016\/j.ejphar.2021.174584_bib33","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2021.174584_bib34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","article-title":"Comparison of the predicted and observed secondary structure of T4 phage lysozyme","volume":"405","author":"Matthews","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174584_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/toxsci\/kfy110","article-title":"Cross-site reliability of human induced pluripotent stem cell-derived cardiomyocyte based safety assays using microelectrode arrays: results from a blinded CiPA pilot study","volume":"164","author":"Millard","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2021.174584_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3389\/fphys.2017.01073","article-title":"Adult human primary cardiomyocyte-based model for the simultaneous prediction of drug-induced inotropic and pro-arrhythmia risk","volume":"8","author":"Nguyen","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2021.174584_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2021.174584_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.vascn.2016.05.016","article-title":"Human ex-vivo action potential model for pro-arrhythmia risk assessment","volume":"81","author":"Page","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2021.174584_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106612","article-title":"Electrophysiological characterization of drug response in hSC-derived cardiomyocytes using voltage-sensitive optical platforms","volume":"99","author":"Pfeiffer-Kaushik","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2021.174584_bib40","series-title":"The BOBYQA Algorithm for Bound Constrained Optimization without Derivatives","author":"Powell Mjd","year":"2009"},{"key":"10.1016\/j.ejphar.2021.174584_bib41","series-title":"R: A Language and Environment for Statistical Computing","author":"R-Project","year":"2019"},{"key":"10.1016\/j.ejphar.2021.174584_bib42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphar.2019.00934","volume":"10","author":"Ribeiro","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174584_bib43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174584_bib44","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1111\/bph.13942","article-title":"Correlation between human ether-a-go-go-related gene channel inhibition and action potential prolongation","volume":"174","author":"Saxena","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174584_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2307\/1422689","article-title":"The proof and measurement of association between two things. By C. Spearman, 1904","volume":"100","author":"Spearman","year":"1987","journal-title":"Am. J. Psychol."},{"key":"10.1016\/j.ejphar.2021.174584_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/cpt.2137","article-title":"Translational models and tools to reduce clinical trials and improve regulatory decision making for QTc and Proarrhythmia risk (ICH E14\/S7B updates)","volume":"109","author":"Strauss","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174584_bib47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0008-6363(02)00714-9","article-title":"Genetic control of sodium channel function","volume":"57","author":"Tan","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2021.174584_bib48","author":"Therneau"},{"key":"10.1016\/j.ejphar.2021.174584_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cpt.2029","article-title":"Time for a fully integrated nonclinical-clinical risk assessment to streamline QT prolongation liability determinations: a pharma industry perspective","volume":"109","author":"Vargas","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174584_bib50","first-page":"28","article-title":"The generalisation of student's problems when several different population variances are involved","volume":"34","author":"Welch","year":"1947","journal-title":"Biometrika"},{"key":"10.1016\/j.ejphar.2021.174584_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167348","article-title":"Electrophysiological characteristics of human iPSC-derived cardiomyocytes for the assessment of drug-induced proarrhythmic potential","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174584_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/toxsci\/kfy264","article-title":"Resolving the reversed rate effect of calcium channel blockers on human-induced pluripotent stem cell-derived cardiomyocytes and the impact on in vitro cardiac safety evaluation","volume":"167","author":"Zeng","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2021.174584_bib53","article-title":"ion channel expression and characterization in human induced pluripotent stem cell-derived cardiomyocytes","volume":"2018","author":"Zhao","year":"2018","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2021.174584_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005407","article-title":"Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes","volume":"4","author":"Zhu","year":"2009","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:54:58Z","timestamp":1757976898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921007408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":54,"alternative-id":["S0014299921007408"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174584","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"174584"}}